Understanding how CD8+ T cells activate the immune system
Mechanisms of CD8+ T cell-induced Innate Immune Activation
['FUNDING_FELLOWSHIP'] · CINCINNATI CHILDRENS HOSP MED CTR · NIH-11065676
This study is looking at how a type of immune cell called CD8+ T cells helps kickstart the body's defense against infections and cancer, and it’s for anyone interested in understanding how we can improve treatments for these health issues.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CINCINNATI CHILDRENS HOSP MED CTR (nih funded) |
| Locations | 1 site (CINCINNATI, UNITED STATES) |
| Trial ID | NIH-11065676 on ClinicalTrials.gov |
What this research studies
This research investigates the role of CD8+ T cells in activating the innate immune system, particularly how these cells can trigger inflammatory responses against pathogens and cancer. The study focuses on the mechanisms by which memory CD8+ T cells interact with myeloid cells to produce important cytokines that help fight infections and tumors. By examining these interactions, the research aims to uncover new insights into immune responses that could enhance therapies for various diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with cancer or chronic infections who may benefit from enhanced immune responses.
Not a fit: Patients with autoimmune disorders or those who do not have a significant immune response may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved immunotherapies for cancer and infectious diseases by harnessing the power of CD8+ T cells.
How similar studies have performed: Previous research has shown promising results in understanding T cell interactions with the immune system, suggesting that this approach could yield valuable insights.
Where this research is happening
CINCINNATI, UNITED STATES
- CINCINNATI CHILDRENS HOSP MED CTR — CINCINNATI, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VALLEZ, CHARLES — CINCINNATI CHILDRENS HOSP MED CTR
- Study coordinator: VALLEZ, CHARLES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: anti-cancer